Journal of Orthomolecular Psychiatry | Libby, A. & Stone, I. (1977)
Historical report evaluating oral administration of high-dose sodium ascorbate (25–85 grams/day) combined with essential vitamins in 30 outpatient individuals undergoing opioid withdrawal.
PubMed Central Review | PMC7572147
Systematic review summarizing published literature on ascorbic acid’s role in attenuating oxidative stress, modulating central neurotransmission, and mitigating withdrawal severity in both animal models and human observational cohorts.
Neuropharmacology / Cell Culture Reports
In vitro and animal model studies demonstrating that high-dose ascorbic acid alters mu-opioid receptor binding kinetics and reduces lipid peroxidation caused by chronic opioid administration.
Explore our detailed analytical articles examining historical timelines, scientific limitations, and evidence standards:
This section contains in-depth research and analysis pages on vitamin C and opioid withdrawal — covering the evidence, its limitations, safety considerations, and form comparisons.
What this research section does not claim:
The existing evidence base represents a signal worth researching. It does not yet support clinical confidence. Anyone managing opioid withdrawal or OUD should explore evidence-based treatment options with a qualified healthcare provider.
These pages help readers evaluate recovery claims critically — distinguishing research signal from hype, anecdote from evidence, and identifying when a “natural” approach carries real risk.
Opiate Freedom Foundation is a 501(c)(3) non-profit organization providing free educational resources on opioid dependence, withdrawal, treatment options, recovery, and related research.